Treats corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva…. Sold as Oxylone, Fml, Fml Forte. Every FDA application for this active ingredient: 4 branded and 3 generic.
As of Nov 15, 2026, FDA lists 7 applications for Fluorometholone (sold as Oxylone, Fml, Fml Forte), first approved Jan 12, 1972, with 0 new uses approved and 0 published complete response letters.
| Fluorometholone | Part D | $31.6M | +2% | 225,212 |
| Fml Forte | Part D | $1.0M | +15% | 2,710 |
| Flarex | Part D | $1.0M | -62% | 4,390 |
| Fml | Part D | $64K | -43% | 164 |
| Innovative Tube Trabeculectomy for Advanced and Refractory Glaucoma: A Randomized Controlled TrialGlaucoma, Trabeculectomy · Benha University | Not applicable | Recruiting | Aug 10, 2026 |
| Vevye + Flarex Combination Therapy for Dry EyeDry Eye · Canyon City Eyecare | Phase 4 | Enrolling by invitation | Apr 28, 2026 |
| Fluorometholone StudyKeratitis Bacterial, Corneal Ulcer (Diagnosis) · Vishal Jhanji | Phase 2 | Not yet recruiting | Dec 30, 2025 |
| The OPTIMISE StudyPseudophakic Bullous Keratopathy, Fuchs' Endothelial Dystrophy · Maastricht University Medical Center | Phase 4 | Recruiting | Feb 8, 2023 |
| Jan 12, 1972 | FmlNDA 16851 · New dosage form | Abbvie | 41 | Marketed |
| Sep 4, 1985 | FmlNDA 17760 · New dosage form | Allergan | 11 | Discontinued |
| Feb 27, 1986 | Fluor-OpANDA 70185 | Novartis | 7 | Discontinued |
| Apr 23, 1986 | Fml ForteNDA 19216 · New dosage form | Abbvie | 24 | Marketed |
| Jan 9, 2024 | FluorometholoneANDA 216348 | Amneal | 0 | Marketed |
| Feb 12, 2026 | FluorometholoneANDA 218819 | Sandoz | 0 | Marketed |
| — | OxyloneNDA 11748 | Pharmacia And Upjohn | 3 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA